Protected: A new treatment breakthrough for non-melanoma skin cancer
This content is password-protected. To view it, please enter the password below. Password:
Browsing: Featured Industry Spotlight
Protected: 2022: A breakthrough year for OncoBeta’s Rhenium-SCT®
This content is password-protected. To view it, please enter the password below. Password:
Interim results from AUS-PREDICT registry show a significant change in radiation treatment recommendations when using DCISionRT test
DCISionRT is a novel molecular test that assesses the 10-year risk of recurrence after Breast…
How can we make integrative oncology care work in regional areas?
Integrative oncology can best be described as patient-centred, evidence-based comprehensive cancer care that includes conventional…
Protected: OncoBeta’s CEO and Managing Director Shannon D. Brown III talks about its innovative non-invasive skin cancer treatment Rhenium-SCT®
This content is password-protected. To view it, please enter the password below. Password:
Protected: The evolving ovarian cancer treatment algorithm: What’s new for your patients in 2022?
This content is password-protected. To view it, please enter the password below. Password:
Protected: PBS listing for BRAFTOVI® (encorafenib) + cetuximab for metastatic colorectal (bowel) cancer patients with a BRAFV600 mutation(1)
This content is password-protected. To view it, please enter the password below. Password:
Protected: New first-in-class treatment for chronic graft-versus-host disease following stem-cell transplant
This content is password-protected. To view it, please enter the password below. Password: